Phase II trial of afatinib in patients with EGFR-mutated solid tumors excluding lung cancer: results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

Autor:	K. Reckamp, Z. Song, S. Gettinger, E.P. Mitchell, J.J. Wright, J.A. Moscow, R.J. Gray, V. Wang, L.M. McShane, L.V. Rubinstein, D.R. Patton, P.M. Williams, S.R. Hamilton, B.A. Conley, C.L. Arteaga, L.N. Harris, P.J. O’Dwyer, A.P. Chen, K.T. Flaherty
Rok vydání:	2022
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 174:S84-S85
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3de6ae0ca4bb490900d120f90c9934e0 https://doi.org/10.1016/s0959-8049(22)01023-1 Zobrazit plný text záznamu Full Text from ScienceDirect